This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jan;7(1):2.

doi: 10.1038/nrendo.2010.203.

Diabetes: Treatment with losartan increases risk of adverse renal outcomes

Claire Greenhill

PMID: 21197702
DOI: 10.1038/nrendo.2010.203

Comment

Diabetes: Treatment with losartan increases risk of adverse renal outcomes

Claire Greenhill. Nat Rev Endocrinol. 2011 Jan.

. 2011 Jan;7(1):2.

doi: 10.1038/nrendo.2010.203.

Author

Claire Greenhill

PMID: 21197702
DOI: 10.1038/nrendo.2010.203

No abstract available

PubMed Disclaimer

Comment on

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Miao Y, Dobre D, Heerspink HJ, Brenner BM, Cooper ME, Parving HH, Shahinfar S, Grobbee D, de Zeeuw D. Miao Y, et al. Diabetologia. 2011 Jan;54(1):44-50. doi: 10.1007/s00125-010-1922-6. Epub 2010 Sep 30. Diabetologia. 2011. PMID: 20882268 Free PMC article. Clinical Trial.

References

1. Diabetologia. 2011 Jan;54(1):44-50 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.